For bacterial and fungal skin infections responsive to ketoconazole or chlorhexidine.
DEFENSIN TECHNOLOGY
________________________________________________________
GLYCOTECHNOLOGY
References:
1. Hillier A, Lloyd DH, Weese JS, et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Vet Dermatol. 2014;25(3):163-e43. doi:10.1111/vde.12118.
2. Santoro D, Ahrens K, Vesny R, et al. Evaluation of the in vitro effect of boldo and meadowsweet plant extracts on the expression of antimicrobial peptides and inflammatory markers in canine keratinocytes. Res Vet Sci. 2017;115:255–262.
3. Santoro D, Kher L, Chala V, Navarro C. Evaluation of the effects of chlorhexidine digluconate with and without cBD103 or cCath against multidrug-resistant clinical isolates of Staphylococcus pseudintermedius. Vet Dermatol. 2022;33(1):17-e6. doi:10.1111/vde.13018.
4. Lloyd DH, Viac J, Werling D, et al. Role of sugars in surface microbe–host interactions and immune reaction modulation. Vet Dermatol. 2007;18:197–204.
Active Ingredients: Chlorhexidine gluconate 2.3% w/w. Ketoconazole 1% w/w.
Inactive Ingredients: Acrylate C10-30 Alkyl Acrylate Crosspolymer, Alkylpolyglucoside, Butylene Glycol, Cocamidopropyl Betaine, d-Galactose, d-Mannose, FD&C Red #4, Fragrance, Hydroxypropyl Methyl Cellulose, l-Rhamnose, Lactic Acid, Laureth-2, Methylchloroisothiazolinone, Methylisothiazolinone, PEG-90 Glyceryl Isostearate, Peumus boldus Leaf Extract, Polyquaternium-7, Purified Water, Sodium Olefin Sulfonate, Spiraea ulmaria Extract, Xanthan Gum.